Biochemistry, Genetics and Molecular Biology
Methylation
100%
Esophagus
99%
Microsatellite Instability
67%
Promoter Region
59%
Carcinogenesis
58%
P53
51%
Colon
49%
Loss of Heterozygosity
48%
MicroRNA
45%
Cancer Cell
42%
Tumor Suppressor Gene
41%
Dysplasia
37%
Epigenetics
27%
Microsatellite DNA
22%
DNA Mismatch Repair
22%
Messenger RNA
21%
Genetics
20%
Metaplasia
20%
Cell Proliferation
20%
Polymerase Chain Reaction
20%
Catenin
20%
Adenomatous Polyposis Coli
20%
Gene Mutation
19%
Polymerase Chain Reaction
18%
Gene Expression
18%
Exon
17%
Signal Transduction
16%
RNA
15%
Coding Region
15%
DNA Methylation
15%
CpG Island
14%
Gene Promoter
14%
Point Mutation
14%
cDNA Microarray
13%
Phosphotransferase
13%
Kinase
13%
Microarrays
13%
Proto Oncogene
13%
Tumor Suppressor Protein
12%
Oncogene
12%
Prevalence
12%
Wnt Signaling Pathway
11%
Circular RNA
11%
SUFU
11%
DNA Sequence
10%
Aneuploidy
10%
Gene Locus
10%
Frameshift Mutation
10%
Cadherin
10%
Eicosanoid Receptor
10%
Medicine and Dentistry
Neoplasm
72%
Barrett Esophagus
68%
Malignant Neoplasm
51%
Esophageal Cancer
48%
Esophageal Adenocarcinoma
48%
Dysplasia
46%
Adenocarcinoma
34%
Microsatellite Instability
33%
Esophagus Carcinoma
33%
Methylation
28%
Carcinogenesis
28%
Promoter Region
26%
Ulcerative Colitis
25%
Gene Expression
24%
Esophagus
24%
Inflammatory Bowel Disease
24%
Esophageal Squamous Cell Carcinoma
21%
Stomach Cancer
21%
microRNA
20%
Biological Marker
20%
Colorectal Cancer
18%
Protein P53
18%
Heterozygosity
17%
Squamous Cell Carcinoma
17%
Carcinoma
17%
Disease
16%
Cell Line
15%
Colon Cancer
15%
Oncogene
14%
Metaplasia
13%
Cancer Cell
12%
Adenomatous Polyposis Coli
12%
Cancer
12%
Gene Mutation
12%
cDNA Microarray
11%
DNA Mismatch Repair
11%
Proto Oncogene
11%
In Vitro
11%
Organoid
10%
Breast Cancer
10%
Tumor Suppressor Gene
10%
Pancreatitis
9%
Colorectal Tumor
9%
Cell Cycle
9%
Patient with Inflammatory Bowel Disease
7%
Complementary DNA
7%
Epithelial Cell
7%
Polymerase Chain Reaction
7%
Stomach Adenocarcinoma
7%
Proliferating Cell Nuclear Antigen
6%
Keyphrases
Barrett's Esophagus
65%
Esophageal Adenocarcinoma
61%
Esophageal Squamous Cell Carcinoma
50%
Esophageal Cancer
39%
Tumor
36%
Microsatellite Instability-high (MSI-H)
35%
Hypermethylation
33%
Gastric Cancer
32%
Esophageal Carcinoma
32%
Ulcerative Colitis
30%
Methylation
30%
Promoter Methylation
27%
Loss of Heterozygosity
24%
Tumor Suppressor Gene
24%
MicroRNA
23%
Inflammatory Bowel Disease
21%
Adenomatous Polyposis Coli
21%
Colorectal Cancer
21%
Adenocarcinoma
20%
Neoplastic Progression
18%
Adenomatous Polyposis Coli Gene
18%
Oncogene
16%
Squamous Cell Carcinoma (SqCC)
14%
Human Esophageal Cancer
14%
Gastric Carcinoma
14%
Barrett
14%
Dysplasia
13%
Colon Cancer
13%
Esophageal Carcinogenesis
13%
Normal Esophagus
13%
Cyclooxygenase-2
13%
Esophageal Tumor
12%
Barrett's Metaplasia
12%
Polymerase Chain Reaction
12%
Adenocarcinoma Cells
11%
Allelic Loss
11%
Complementary DNA (cDNA)
11%
Catenin
10%
Tumor Protein p53 (TP53)
10%
Colitis-associated Dysplasia
10%
High-grade Dysplasia
10%
Gene Promoter
10%
MRNA Expression
10%
Human Gastric Cancer
10%
Human Gastric Carcinoma
10%
Breast Cancer
9%
Early Events
9%
Esophageal Cancer Cells
9%
Overexpression
9%
Colon Adenocarcinoma
9%